|
||||
Health Network > Diseases & Conditions > Chronic Liver Disease and Cirrhosis |
||||
Weight
Loss Mens
Health Womens Health Skin & Beauty Diseases
& Conditions Substance Use / Addictions Exercise
& Training |
Chronic Liver Disease and Cirrhosis
Chronic liver disease is a health problem that results in the progressive destruction and deterioration of the liver. The disease, which develops at a slow process, lasts for a long period of time. There are various types of chronic liver disease. One of them is cirrhosis of the liver. Cirrhosis of the liver is a disease characterized by the replacement of the liver tissue by a fibrotic scar tissue and regenerative nodules, thus resulting in the progressive deterioration of the liver. Ascites, a condition wherein fluid is retained in the abdominal cavity, is the most common complication of this chronic liver disease. Other complications include bleeding from esophageal varices and hepatic encephalogy (coma and confusion). Once cirrhosis develops, it is generally irreversible and its treatment focuses more on the prevention of the complications and progression of the disease. What causes Cirrhosis? What are the symptoms of Cirrhosis? How is cirrhosis diagnosed? How is it treated? Elimination of causes. Since alcoholic cirrhosis is caused by alcoholism, the intake of alcohol is discouraged. Meanwhile, the treatment for hepatitis-related cirrhosis includes medications for different kinds of hepatitis like corticosteroids for autoimmune hepatitis and interferon for viral hepatitis. Cirrhosis, which is caused by Wilson's disease (the accumulation of copper in organs), is treated with chelation therapy. Preventing complications. Diuretics may be used in order to suppress ascites. Antibiotics are prescribed for infections, while other medications to reduce or control itching may be taken. Laxatives like lactulose lessen the risk of constipation. Meanwhile, propranolol is prescribed for portal hypertension. This medication is necessary in order to lower the blood pressure in the portal system. Severe cases. Transjugular intrahepatic portosystemic shunting may be needed to treat severe complications due to portal hypertension. This treatment is used in order to relieve pressure in the portal vein. But transjugular intrahepatic portosystemic shunting is only administered to patients with a low risk of encephalopathy because this treatment can worsen such health problem. It is also considered only as a palliative measure or a bridge to liver transplantation. A liver transplantation may be needed when the liver ceases to function or when complications can no longer be controlled. Currently, the survival rate of patients undergoing liver transplantation is 90%. The success of the operation depends on the stage of the disease and the health condition of patients. Prevention of cirrhosis | |||
This site is designed to give general health information solely for educational purposes. © 2005 Health Network | Privacy Policy |